Advanced Search

 

Study ID Status Title Patient Level Data
116136 Completed A multicenter, randomized, double-blind, parallelgroup study to evaluate the efficacy and safety of the addition of umeclidinium bromide Inhalation Powder (62.5mcg) once-daily to fluticasone propionate/salmeterol (250/50mcg) twice-daily, umeclidinium bromide Inhalation Powder (125mcg) once-daily to fluticasone propionate/salmeterol (250/50mcg) twice-daily versus placebo to fluticasone propionate/salmeterol (250/50mcg) twice-daily over 12 weeks in subjects with COPD. Study Listed on ClinicalStudyDataRequest.com
116170 Completed A 52-Week, Open-Label, Multicenter Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination with Monotherapy of Oral Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
116197 Completed A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE (LATITUDE)-TIMI 60. Study Listed on ClinicalStudyDataRequest.com
116216 Completed An interaction study to assess the effect of the ezogabine/retigabine and the main metabolite NAMR on the pharmacokinetics of digoxin in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
116266 Terminated A Three-Part Phase I, Open-Label, Single Ascending Dose, and A Single-Blind, Placebo-Controlled, Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Relative Bioavailability of Intravenous and Oral GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects Study Listed on ClinicalStudyDataRequest.com
116281 Completed Persistence and Compliance among United States patients with advanced Renal Cell Carcinoma receiving treatment with Pazopanib
116317 Completed Sentinel surveillance for influenza requiring hospital admission in Canadian adults
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116343 Completed A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
116357 Completed Burden of respiratory syncytial virus (RSV) in the United Kingdom, 1995 to 2009
116364 Completed Study FFR116364, a double-blind, placebo-controlled study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116365 Completed Study FFR116365, an open-label study of GW685698X in paediatric subjects with perennial allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
116371 Completed A Phase 1, Open-Label, Crossover Study to Demonstrate the Bioequivalence of RYTHMOL SR® (propafenone hydrochloride) Manufactured at Two Different Sites Study Listed on ClinicalStudyDataRequest.com
116378 Completed A Single Blind (Sponsor-unblinded), Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of GSK1070806 in the Treatment of Obese Subjects with T2DM. Study Listed on ClinicalStudyDataRequest.com
116392 Completed A randomized, double blind, placebo-controlled study to investigate the safety and pharmacodynamics of repeat intranasal administration of the TLR7 agonist GSK2245035 in subjects with respiratory allergies Study Listed on ClinicalStudyDataRequest.com
116402 Completed A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma Study Listed on ClinicalStudyDataRequest.com
116415 Completed A randomized, double-blind, single dose, four way cross-over study to assess the systemic exposure, systemic pharmacodynamics and safety and tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol following single inhaled doses of Umeclidinium/Vilanterol blend + Fluticasone Furoate, Umeclidinium + Vilanterol, Fluticasone Furoate + Vilanterol and Fluticasone Furoate + Umeclidinium in healthy subjects Study Listed on ClinicalStudyDataRequest.com
116416 Completed Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Study Listed on ClinicalStudyDataRequest.com
116441 Completed Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension. - A Single Oral Dose Study to Investigate Pharmacokinetics of Atovaquone and Proguanil from Combination Tablets and Atovaquone from Atovaquone Suspension in Japanese Healthy Males. -
116454 Active, Not Recruiting Special Drug Use Investigation for ReQuip® Controlled-Release (CR)
116455 Completed A Multi-Center, Open-labelled Study to Evaluate the Safety of Levocetirizine Hydrochloride Oral Solution in Children Aged 6 Months to 2 Years with Allergic Rhinitis or Pruritus Associated with the Skin Diseases.
116456 Recruiting A Post-Marketing Surveillance Study of Requip PD™ (Ropinirole) in the Treatment of Adult Filipino Patients diagnosed with Parkinson’s Disease
116459 Completed Pharmacokinetic Study of Levocetirizine Oral Solution-An open-label, randomized, cross-over study to evaluate the pharmacokinetics, the safety and tolerability of levocetirizine oral solution (5 mg) and cetirizine dry syrup (10 mg), following a single dose in Japanese healthy male subjects-
116477 Completed Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis Study Listed on ClinicalStudyDataRequest.com
116480 Completed An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, adult, human subjects, under fasting conditions Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.